Osmosis Investment Management UK Ltd Invests $1.24 Million in Humana Inc. $HUM

Osmosis Investment Management UK Ltd purchased a new position in shares of Humana Inc. (NYSE:HUM) in the 2nd quarter, HoldingsChannel.com reports. The fund purchased 3,128 shares of the insurance provider’s stock, valued at approximately $1,243,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Johnson Financial Group Inc. acquired a new position in shares of Humana during the second quarter valued at approximately $26,000. Trust Co. of Vermont acquired a new stake in shares of Humana in the second quarter worth approximately $28,000. Bogart Wealth LLC increased its position in shares of Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after purchasing an additional 48 shares in the last quarter. MidFirst Bank purchased a new stake in shares of Humana during the second quarter worth approximately $35,000. Finally, Montag A & Associates Inc. raised its stake in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Performance

NYSE:HUM opened at $386.43 on Tuesday. The company’s 50-day moving average is $383.50 and its two-hundred day moving average is $283.61. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a market capitalization of $46.40 billion, a price-to-earnings ratio of 36.56, a PEG ratio of 2.17 and a beta of 0.72.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business’s revenue was up 26.2% compared to the same quarter last year. During the same quarter last year, the firm earned $6.27 EPS. Analysts forecast that Humana Inc. will post 9.08 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Seaport Research Partners cut shares of Humana to a “neutral” rating in a research note on Wednesday, May 20th. TD Cowen raised their price target on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a research note on Friday, July 31st. Leerink Partners upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price target on the stock in a research report on Thursday, July 30th. Robert W. Baird set a $390.00 price target on shares of Humana in a research report on Thursday, July 30th. Finally, Truist Financial increased their price objective on shares of Humana from $320.00 to $415.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $403.91.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.